2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Dermatologic
1
Conditions
Carcinoma, Basal Cell
6
Lung Neoplasms
4
Breast Neoplasms
3
Skin Neoplasms
2
Precancerous Conditions
2
Pancreatic Neoplasms
2
Neoplasms
2
Keratosis, Actinic
2
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Telangiectasis
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Rosacea
1
Recurrent respiratory papillomatosis
1
Prostatic Neoplasms
1
Port-Wine Stain
1
Pancreatic Intraductal Neoplasms
1
Non-melanoma Skin Cancer
1
Nevus, Pigmented
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Mouth Diseases
1
Mixed Tumor, Malignant
1
Mesothelioma, Malignant
1
Melanoma
1
Lichen Planus, Oral
1
Leukoplakia, Oral
1
Interventions
Cyclophosphamide
64
Tacrolimus
55
Methotrexate
46
Mycophenolic Acid
39
Cyclosporine
37
fludarabine phosphate
35
Busulfan
35
Antilymphocyte Serum
32
fludarabine
29
Sirolimus
26
Melphalan
23
Peripheral Blood Stem Cell Transplantation
22
Radiotherapy
21
Methylprednisolone
21
Whole-Body Irradiation
19
Filgrastim
17
thymoglobulin
14
Thiotepa
11
Stem Cell Transplantation
10
Rituximab
10
ruxolitinib
9
Granulocyte Colony-Stimulating Factor
9
Prednisone
7
Hematopoietic Stem Cell Transplantation
7
Etoposide
7
Cord Blood Stem Cell Transplantation
7
Alemtuzumab
7
Transplantation
6
Pentostatin
6
Cytarabine
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Graft vs Host Disease
×
Tomography, Optical Coherence
×
Clear all
NCT06321003
2025-05-23
SYMILIS OCT
University of Palermo
Recruiting
200 enrolled